BNGO vs CNC · rev $14.9M vs P/E 8.4, rev $103.52B
Bionano Genomics Inc (BNGO) versus Centene Corp (CNC) — a side-by-side from cached financials, not a winner call.
Bionano Genomics Inc (BNGO) is a medical instruments & supplies company listed on US.
Centene Corp (CNC) is a healthcare plans company listed on US.
Latest reported BNGO revenue for 2026-06-30 was $14.9M. Net income was -$15.7M. BNGO currently screens at market cap $13.4M.
Latest reported CNC revenue for 2026-06-30 was $103.52B. Net income was $2.63B. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
BNGO currently screens at market cap $13.4M. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Not investment advice. Open the BNGO and CNC stock pages for the full models.
Not investment advice.